From Drew Altman: Trump Has No Health Plan, He Has the Art of the Health Care Deal

In his first column for the new year, KFF CEO Dr. Drew Altman analyzes President Trump’s “make a deal” approach to health care. He explains that while the president doesn’t have a health reform plan, or even “concepts of a plan,” or a replacement for the ACA, he does have a distinctive set of tactics that features one-off deals with the health care industry that are more like “health policy by transaction.” He writes that the deals “even do some good,” but “don’t change the long-term incentives of the health care companies that participate in the deals,” and a big question is “whether they have staying power.”

Affordable Care Act

Updated Larry QT on ePTCs

There is No Drop-Dead Date for an ACA Tax Credit Extension, But Coverage Losses Will Mount as the Clock Ticks

A discharge petition in the House paves the way for a vote on a three-year extension of the tax credits, which would provide ACA enrollees premium relief whenever it comes. While there is still time to extend the enhanced tax credits, with each passing day, more and more ACA Marketplace enrollees are going to drop their health insurance when faced with eye-popping increases in their premium payments, writes KFF’s Larry Levitt.

Policy Changes Bring Renewed Focus on High-Deductible Health Plans 

Policy changes, anticipated increases in premium costs for enrollees, and new standards for health savings accounts may encourage consumers to seek out plans with lower premiums but higher deductibles. This issue brief explores the features of bronze and catastrophic plans, coverage and costs, and the complicated choices consumers face.

Timely insights and analysis from KFF staff

new and noteworthy

ACIP Vote Drives Online Engagement About Hepatitis B Vaccine

Nearly two weeks after a CDC advisory panel voted to end the recommendation for newborn hepatitis B vaccination, conversations about vaccination schedules and parental choice remain elevated. This volume of the Monitor explores this and other recent developments in health information.

What to Know About PBMs and Federal Efforts at Regulation

This brief provides an overview of the role of Pharmacy Benefit Managers (PBMs), discusses recent federal legislation focusing on several elements of PBM business practices, and explains the potential federal budgetary impact of this legislation.

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here